Dynatrace, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated November 15, 2023 and signed November 17, 2023, reports Dynatrace’s entry into an underwriting agreement for a secondary offering of its common stock. The filing does not provide an operating-period financial update.
Transaction and Key Financial Metrics
- Selling stockholders agreed to sell 10,000,000 shares of common stock at $50.00 per share.
- The implied gross offering value is $500 million, payable to the selling stockholders.
- The underwriter received a 30-day option to purchase up to an additional 1,500,000 shares.
- Dynatrace will not receive any proceeds from the offering.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics.
Material Changes Versus the Prior Comparable Period
No comparable-period financial information or operating changes are reported. The material event is the planned secondary sale of existing shares, which is not a primary issuance by Dynatrace.
Guidance, Outlook, Risks, and Unusual Items
- The offering was expected to close on or about November 17, 2023, subject to customary closing conditions.
- The transaction was registered under Dynatrace’s automatic shelf registration statement on Form S-3, filed November 15, 2023.
- The filing incorporates the underwriting agreement, legal opinion, and launch and pricing press releases as exhibits.
- Potential transaction-related risks include failure to satisfy closing conditions and possible additional selling pressure from the resale of the offered shares or exercise of the underwriter’s option.
- The filing text does not provide additional management guidance or a broader business outlook.
Key Facts for Investors to Verify
- Whether the offering closed as expected and whether the underwriter exercised any portion of its 1,500,000-share option.
- The final number of shares sold and the resulting public-share float and ownership percentages.
- That Dynatrace received no offering proceeds and that the transaction was a sale by existing stockholders.
- The terms and any additional obligations contained in the underwriting agreement and related prospectus supplement.
- Any market or business updates included in the incorporated launch and pricing press releases.